Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure - PubMed (original) (raw)
. 2002 Jan 22;166(2):219.
- PMID: 11826947
- PMCID: PMC99278
Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure
Eric Wooltorton. CMAJ. 2002.
No abstract available
Similar articles
- Pioglitazone and rosiglitazone for diabetes.
[No authors listed] [No authors listed] Drug Ther Bull. 2001 Sep;39(9):65-8. Drug Ther Bull. 2001. PMID: 11586802 Review. - Pioglitazone (Actos).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1999 Nov 19;41(1066):112. Med Lett Drugs Ther. 1999. PMID: 10987011 No abstract available. - Actos (pioglitazone).
[No authors listed] [No authors listed] TreatmentUpdate. 2001 Nov-Dec;13(7):5-6. TreatmentUpdate. 2001. PMID: 11794862 No abstract available. - Thiazolidinediones for type 2 diabetes. All glitazones may exacerbate heart failure.
Benbow A, Stewart M, Yeoman G. Benbow A, et al. BMJ. 2001 Jan 27;322(7280):236. BMJ. 2001. PMID: 11159623 No abstract available. - Rosiglitazone and the thiazolidinediones: a changing context.
Kenny C. Kenny C. Prim Care Diabetes. 2007 Dec;1(4):185-6. doi: 10.1016/j.pcd.2007.10.043. Epub 2007 Dec 3. Prim Care Diabetes. 2007. PMID: 18632043 Review. No abstract available.
Cited by
- The forgotten type 2 diabetes mellitus medicine: rosiglitazone.
Xu B, Xing A, Li S. Xu B, et al. Diabetol Int. 2021 Jun 29;13(1):49-65. doi: 10.1007/s13340-021-00519-0. eCollection 2022 Jan. Diabetol Int. 2021. PMID: 35059243 Free PMC article. Review. - Thiazolidinediones: the Forgotten Diabetes Medications.
Lebovitz HE. Lebovitz HE. Curr Diab Rep. 2019 Nov 27;19(12):151. doi: 10.1007/s11892-019-1270-y. Curr Diab Rep. 2019. PMID: 31776781 Free PMC article. Review. - Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
Patel PA, Liang L, Khazanie P, Hammill BG, Fonarow GC, Yancy CW, Bhatt DL, Curtis LH, Hernandez AF. Patel PA, et al. Circ Heart Fail. 2016 Jul;9(7):10.1161/CIRCHEARTFAILURE.115.002638 e002638. doi: 10.1161/CIRCHEARTFAILURE.115.002638. Circ Heart Fail. 2016. PMID: 27413035 Free PMC article. - Understanding the Impact of Electronic Medical Record Use on Practice-Based Population Health Management: A Mixed-Method Study.
Vaghefi I, Hughes JB, Law S, Lortie M, Leaver C, Lapointe L. Vaghefi I, et al. JMIR Med Inform. 2016 Apr 4;4(2):e10. doi: 10.2196/medinform.4577. JMIR Med Inform. 2016. PMID: 27044411 Free PMC article. - Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors in the Management Of Type-2 Diabetes: A Drug Class Overview.
Mosley JF 2nd, Smith L, Everton E, Fellner C. Mosley JF 2nd, et al. P T. 2015 Jul;40(7):451-62. P T. 2015. PMID: 26185406 Free PMC article.
References
- Important safety reminder for patients taking oral diabetes drugs of the glitazone class, Avandia® and Actos®. Ottawa: Health Canada; 2001 Nov 30. Available: www.hc-sc.gc.ca/english/protection/warnings/2001/2001_132e.htm (accessed 2001 Dec 17).
- Important safety information regarding Avandia® (rosiglitazone maleate). Mississauga (ON): GlaxoSmithKline; 2001 Nov 13. Available: www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/advisory/industry/avan... (accessed 2001 Dec 17).
- Important safety information regarding Actos®. Toronto: Eli Lilly Canada Inc.; 2001 Nov 6. Available: www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/advisory/industry/acto... (accessed 2001 Dec 17).
- McMorran M, Vu D. Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions. Can ADR Newsl 2001;11(3):2-3. Also in CMAJ 2001; 165(1):82-3. Available: www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/publicat/adrv11n3_e.html (accessed 2001 Dec 17). - PubMed
- Avandia®, rosiglitazone maleate tablets [product monograph]. Mississauga (ON): GlaxoSmithKline; 2001 Oct 19.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical